Today on in-pharmatechnologist.com   Japan's Tamiflu supply halved Neural stem cell drug delivery is encapsulating FDA failure on foreign inspections frightening GSK, Fabre-Kramer lose out on antidepressant Flutiform safety results a 'significant milestone'

Related Industry News   Pretender to Avastin throne poised to enter clinical trails Sigma-Aldrich halves miRNA preparation times Quintiles makes Panama purchase Clinical contract news in brief

Breaking News on Pharmaceutical Technology - Europe
Daily  Monday 05 November 2007		Forward to a colleague

	Sponsored Link New filler/binder for ODT production Latest research shows that PALATINIT's galenIQ™ 720 and 721 are perfect alternatives for ODT formulations due to a fast disintegration time even without additional super-disintegrants... Click Here Access Full Stories Japan's Tamiflu supply halved Japan will only be receiving 50 per cent of its usual supply of the blockbuster flu drug Tamiflu (oseltamivir) this year, thanks to significantly reduced demand following reports of suicidal behaviour in adolescents... Read Neural stem cell drug delivery is encapsulating Inherited genetic disorders could be treated with a new stem cell-based drug delivery therapy through the use of microcapsules... Read FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants... Read GSK, Fabre-Kramer lose out on antidepressant GlaxoSmithKline (GSK) and Fabre-Kramer Pharmaceuticals (FKP) were dealt a blow last week as their potential first in class, once-daily antidepressant treatment received another thumbs down from US regulators... Read Flutiform safety results a 'significant milestone' UK-based SkyePharma has been given a boost in regards to its asthma treatment following the release of positive Phase III results... Read
	All News Headlines for: November | October | September
	Sponsored Link Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here
	Advertisement Related Industry News Pretender to Avastin throne poised to enter clinical trails BioInvent and ThromboGenics' new anticancer antibody is poised to enter clinical trials and could prove a serious rival to VEGF-blocking drugs, due to fewer side-effects and less drug resistance... Read Sigma-Aldrich halves miRNA preparation times Sigma-Aldrich has continued its push into the RNAi field with the launch of its new mirPremier miRNA (microRNA) isolation kit that promises to speed up miRNA preparation while removing all large, unwanted RNA... Read Quintiles makes Panama purchase Quintiles has bought a contract research organisation (CRO) in Central America to extend its reach in this emerging clinical trials region... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that featured in the clinical contract community this past week, involving PPD, Novotech and Generex... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Supremely Flexible: Spray Drying from Niro The new PSD-1 pharmaceutical spray dryer from Niro allows you to perform exacting R&D as well as production of IMP's and small-scale manufacturing with one and the same unit. Drying with the PHARMASD series of spray dryers gives you optimum control of product properties... Click Here Previous Headlines Valeritas insulin delivery device gets a name US-based Valeritas has announced the brand name for its lead candidate disposable insulin delivery device - V-Go... Read Pharma must 'reinvent' itself to survive With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent... Read Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry... Read SCOLR on track for first 12-hour ibuprofen SCOLR Pharma has initiated the first of three pivotal trials to evaluate its extended release ibuprofen tablet, with hopes that it will be the first and only 12-hour formulation on the market... Read GSK blocks new patent rules Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules... Read Product Information - brochures, Web centers The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com